Treatment pattern and outcomes of trifluridine/tipiracil therapy for metastatic colorectal cancer in the real-world data from the JFMC50 study

T. Kawakami, K. Yamazaki, E. Oki, M. Shimokawa, N. Takahashi, M. Yokota, S. Tokunaga, T. Esaki, M. Gamoh, A. Maeda, Y. Tsuji, A. Sakai, K. Hatanaka, Y. Shimada, M. Shiozawa, Y. Komatsu, H. Okuda, M. Ohue, Y. Maehara

研究成果: ジャーナルへの寄稿記事

元の言語英語
ページ(範囲)viii155
ジャーナルAnnals of oncology : official journal of the European Society for Medical Oncology
29
DOI
出版物ステータス出版済み - 10 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

これを引用

Kawakami, T., Yamazaki, K., Oki, E., Shimokawa, M., Takahashi, N., Yokota, M., Tokunaga, S., Esaki, T., Gamoh, M., Maeda, A., Tsuji, Y., Sakai, A., Hatanaka, K., Shimada, Y., Shiozawa, M., Komatsu, Y., Okuda, H., Ohue, M., & Maehara, Y. (2018). Treatment pattern and outcomes of trifluridine/tipiracil therapy for metastatic colorectal cancer in the real-world data from the JFMC50 study. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii155. https://doi.org/10.1093/annonc/mdy281.013